The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

Startups are addressing the technical challenges of getting something that can compete with low-cost herbicides.

Ginkgo Bioworks (NYSE: DNA) today announced that the company has extended its multi-year strategic partnership with Bayer to ...

However, conventional chemical synthesis methods have many side reactions and high environmental burdens, and existing ...

Nootropics Depot is redefining the landscape of dietary supplements through its uncompromising research and development (R&D) ...

Following 10 years of global and five years of Australian trials, FMC has applied to the APVMA for approval of an Integrated ...

Enterprise platform, queried through natural language, to help pharma, biotech, and investors make better decisions. High-quality biological patient data, enriched and integrated for use by AI agents.

ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced that it has entered into a license and collaboration agreement with Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) to ...

The growing use of GLP-1 drugs presents opportunities for food manufacturers but what must NPD teams consider?

Explore how dairy alternative brands like PlanetDairy, Rude Health, and ImaginDairy are innovating through hybrid, ...

US FDA moves to accelerate biosimilar development and lower drug costs: Maryland Friday, October 31, 2025, 14:00 Hrs [IST] The US Food and Drug Administration (FDA) announced sign ...